<?xml version="1.0" encoding="iso-8859-1"?>
<?xml-stylesheet type="text/xsl" href="http://www.physorg.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0">
<channel>
<title>PHYSorg.com: PHYSorg news tagged with: survival benefit</title>
<link>http://www.physorg.com/</link>
<language>en-us</language> 
<description>Physorg.com internet news portal provides the latest news on science including: Physics, Nanotechnology, Life Sciences, Space Science, Earth Science, Environment, Health and Medicine.</description>

 <item>
     <title>Donor stem cell transplantation associated with survival benefit for patients with leukemia</title>
   	 <description>An analysis of previous studies indicates that allogeneic stem cell transplantation (SCT) (stem cells from a compatible donor) is associated with significant overall and relapse-free survival benefit among adult patients with intermediate- and poor-risk but not good-risk acute myeloid leukemia in first complete remission, compared with nonallogeneic SCT therapies, according to an article in the June 10 issue of JAMA. </description>
     <link>http://www.physorg.com/news163822596.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 10 Jun 2009 03:16:59 EST</pubDate>
	 <guid isPermaLink="false">news163822596</guid>
</item>
<item>
     <title>High-flux hemodialysis prolongs survival in many patients with CKD</title>
   	 <description>High-flux hemodialysis (which removes large toxins) reduces the risk of premature death in many patients with chronic kidney disease (CKD), according to a study appearing in the March 2009 issue of the Journal of the American Society Nephrology (JASN). The results suggest that this procedure could be beneficial for those with poor prognoses and those with diabetes.</description>
     <link>http://www.physorg.com/news154355153.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Fri, 20 Feb 2009 12:26:48 EST</pubDate>
	 <guid isPermaLink="false">news154355153</guid>
</item>
<item>
     <title>Radiofrequency treatment better than ethanol injection for small liver tumors</title>
   	 <description>A new review of four randomized controlled trials that directly compared two different treatments for small inoperable liver tumors has found that radiofrequency ablation (RFA) significantly improves patient survival compared to the standard therapy of percutaneous ethanol injection (PEI). These findings are in the February issue of Hepatology, a journal published by John Wiley &amp; Sons on behalf of the American Association for the Study of Liver Diseases (AASLD). </description>
     <link>http://www.physorg.com/news152899105.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 03 Feb 2009 15:58:46 EST</pubDate>
	 <guid isPermaLink="false">news152899105</guid>
</item>


</channel>
</rss>

